Consort Nt [MLCNT] vs Capgemini SE [CAP] Detailed Stock Comparison
Consort Nt
Euronext
Loading...
Capgemini SE
Euronext
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Consort Nt wins in 9 metrics, Capgemini SE wins in 3 metrics, with 0 ties. Consort Nt appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Consort Nt | Capgemini SE | Better |
|---|---|---|---|
| P/E Ratio (TTM) | N/A | 13.95 | N/A |
| Price-to-Book Ratio | 3.37 | 1.92 | Capgemini SE |
| Debt-to-Equity Ratio | 0.41 | 55.23 | Consort Nt |
| PEG Ratio | N/A | 10.26 | N/A |
| EV/EBITDA | 0.00 | 8.64 | Consort Nt |
| Profit Margin (TTM) | 45.36% | 7.07% | Consort Nt |
| Operating Margin (TTM) | 94.77% | 10.31% | Consort Nt |
| EBITDA Margin (TTM) | 94.77% | 10.31% | Consort Nt |
| Return on Equity | 32.15% | 14.32% | Consort Nt |
| Return on Assets (TTM) | 25.19% | 6.24% | Consort Nt |
| Free Cash Flow (TTM) | N/A | $2.21B | N/A |
| Dividend Yield | 2.57% | N/A | N/A |
| 1-Year Return | 0.00% | -28.74% | Consort Nt |
| Price-to-Sales Ratio (TTM) | 16.79 | 0.97 | Capgemini SE |
| Enterprise Value | $0 | $24.63B | Capgemini SE |
| EV/Revenue Ratio | 0.00 | 1.12 | Consort Nt |
| Gross Profit Margin (TTM) | 35.39% | N/A | N/A |
| Revenue per Share (TTM) | N/A | $130 | N/A |
| Earnings per Share (Diluted) | N/A | $8.87 | N/A |
| Beta (Stock Volatility) | N/A | 0.96 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Consort Nt vs Capgemini SE Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Consort Nt | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Capgemini SE | 1.45% | 0.92% | -12.20% | -13.11% | -28.94% | -19.82% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Consort Nt | 0.00% | 738.32% | 40.00% | 288.89% | 366.67% | 366.67% |
| Capgemini SE | -28.74% | -33.21% | 12.80% | 46.25% | 342.25% | 342.25% |
Performance & Financial Health Analysis: Consort Nt vs Capgemini SE
| Metric | MLCNT | CAP |
|---|---|---|
| Market Information | ||
| Market Cap | €145.28M | €21.51B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 2 | 540,100 |
| 90 Day Avg. Volume | 1 | 474,675 |
| Last Close | €70.00 | €125.60 |
| 52 Week Range | €70.00 - €70.00 | €110.00 - €199.90 |
| % from 52W High | 0.00% | -37.17% |
| All-Time High | €70.00 (Feb 20, 2023) | €227.40 (Mar 04, 2024) |
| % from All-Time High | 0.00% | -44.77% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.01% | 0.00% |
| Quarterly Earnings Growth | N/A | -0.13% |
| Financial Health | ||
| Profit Margin (TTM) | 0.45% | 0.07% |
| Operating Margin (TTM) | 0.95% | 0.10% |
| Return on Equity (TTM) | 0.32% | 0.14% |
| Debt to Equity (MRQ) | 0.41 | 55.23 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €14.50 | €64.56 |
| Cash per Share (MRQ) | N/A | €12.42 |
| Operating Cash Flow (TTM) | €766.92M | €2.44B |
| Levered Free Cash Flow (TTM) | €1.42B | €2.33B |
| Dividends | ||
| Last 12-Month Dividend Yield | 2.57% | N/A |
| Last 12-Month Dividend | €1.80 | N/A |
Valuation & Enterprise Metrics Analysis: Consort Nt vs Capgemini SE
| Metric | MLCNT | CAP |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | N/A | 13.95 |
| Forward P/E | N/A | 10.26 |
| PEG Ratio | N/A | 10.26 |
| Price to Sales (TTM) | 16.79 | 0.97 |
| Price to Book (MRQ) | 3.37 | 1.92 |
| Market Capitalization | ||
| Market Capitalization | €145.28M | €21.51B |
| Enterprise Value | €0 | €24.63B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.00 | 1.12 |
| Enterprise to EBITDA | 0.00 | 8.64 |
| Risk & Other Metrics | ||
| Beta | N/A | 0.96 |
| Book Value per Share (MRQ) | €14.50 | €64.56 |
Financial Statements Comparison: Consort Nt vs Capgemini SE
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | MLCNT | CAP |
|---|---|---|
| Revenue/Sales | €378.92M | N/A |
| Cost of Goods Sold | €244.84M | N/A |
| Gross Profit | €134.08M | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | €118.65M | N/A |
| EBITDA | €195.10M | N/A |
| Pre-Tax Income | €78.05M | N/A |
| Income Tax | €102.36M | N/A |
| Net Income (Profit) | €-24.31M | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | MLCNT | CAP |
|---|---|---|
| Cash & Equivalents | €253.55M | €2.79B |
| Total Current Assets | €589.40M | €9.31B |
| Total Current Liabilities | €301.14M | €7.71B |
| Long-Term Debt | €401.35M | €4.95B |
| Total Shareholders Equity | €1.29B | €11.80B |
| Retained Earnings | €-3.24B | €7.21B |
| Property, Plant & Equipment | €218.45M | €2.07B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | MLCNT | CAP |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | MLCNT | CAP |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 2 | 540,100 |
| Average Daily Volume (90 Day) | 1 | 474,675 |
| Shares Outstanding | 2.20M | 169.95M |
| Float Shares | N/A | 169.62M |
| % Held by Insiders | N/A | 0.09% |
| % Held by Institutions | N/A | 0.71% |
Dividend Analysis & Yield Comparison: Consort Nt vs Capgemini SE
| Metric | MLCNT | CAP |
|---|---|---|
| Last 12-Month Dividend | €1.80 | N/A |
| Last 12-Month Dividend Yield | 2.57% | N/A |
| 3-Year Avg Annual Dividend | €1.80 | N/A |
| 3-Year Avg Dividend Yield | 9.26% | N/A |
| 3-Year Total Dividends | €5.40 | N/A |
| Ex-Dividend Date | Jul 15, 2024 | N/A |